While several reviews have surveyed inflammation in PCOS broadly, few have undertaken quantitative meta-analysis focusing on TNF-α with robust exploration, and despite consistent elevation of inflammatory markers, TNF-α’s clinical interpretability as a biomarker for PCOS severity or phenotype differentiation remains uncertain [2-6]. The gene discussed is TNF; the disease is polycystic ovary syndrome.